Milestone Pharmaceuticals is trading 9.02% higher at $0.76 in after-hours trading, with no verified company-specific announcement explaining the move.
- The stock closed the October 21 regular session at $0.70.
- The broader market finished higher, and reporting noted healthcare strength; available evidence does not establish either as a cause of the extended-hours gain.
- The company’s October 19 cardiology-conference announcement predates the move and is not a confirmed catalyst.